Andere Sprachen Celon Pharma S.A.

Aktien

A2DJW6

PLCLNPH00015

CLN

Markt geschlossen - Warsaw S.E. Andere Börsenplätze 17:55:44 02.05.2024			% 5 Tage	% 1. Jan.
15.52 ^PLN	+2.37%		+1.84%	+0.39%

24.04.	Celon Pharma S.A. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr	CI
2023	Celon Pharma S.A. meldet Ergebnis für das dritte Quartal und die neun Monate bis zum 30. September 2023	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Celon Pharma S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	24.04.
Celon Pharma S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	22.11.
Celon Pharma S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	20.09.23
Celon Pharma S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023	24.05.23
Celon Pharma S.A. Reports Earnings Results for the Full Year Ended December 31, 2022	26.04.23
Celon Pharma S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	23.11.22
Celon Pharma S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	28.09.22
Celon Pharma S.A. Reports Earnings Results for the First Quarter Ended March 31, 2022	25.05.22
Celon Pharma S.A. Reports Earnings Results for the Full Year Ended December 31, 2021	02.05.22
Celon Pharma S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	29.11.21
The results of CPL’36 – PDE10a inhibitor to be presented in the poster session at Neuroscience 2021.	02.11.21
Celon Pharma S.A. at the Jefferies Healthcare Conference 2021.	26.10.21
Celon Pharma S.A. Reports Earnings Results for the Second Quarter Ended June 30, 2021	30.09.21
Celon Pharma S A : Doubled export sales, continuation of the strategy of investing in research and development	30.09.21
Celon Pharma S A : 3 posters to be published at 34th ECNP Congress	14.09.21
Celon Pharma Successfully Completes the First Stage of Clinical Research into its CPL'116 Drug Candidate for Treating Autoimmune Diseases	10.08.21
Celon Pharma to Raise PLN 216mn in Public Offering	12.07.21
Celon Pharma Files for Approval of Phase II Trial of CPL’280, a Second Generation GPR40 Agonist, in Type 2 Diabetes	22.06.21
Celon Pharma S A : at EASD 2021	15.06.21
Celon Pharma S A : Dynamic export and continuation of positive trends in the development of innovative products	26.05.21

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Celon Pharma S.A.

Aktien

A2DJW6

PLCLNPH00015

CLN

Andere Sprachen

Filter